David Reinstein: I have argued against this idea of ‘room for more funding’ as a binary thing.
generally imagine in these areas there is always room for more funding, at least in the horizon of a year or more.
It’s just a combination of
diminishing returns, perhaps past a threshold of ‘these interventions are better than alternatives’
limited capacity because of short-run constraints that take some time to adjust (hire more staff, negotiate more vaccine access, assess new areas to administer vaccines)
Almost no cost function should have an ‘infinite slope’ past a certain output, particularly not in the non-very-short run. Similarly here.
“Room for more funding”: A critique/explanation
Status: WIP, rough, needs consolidating
David Reinstein: I have argued against this idea of ‘room for more funding’ as a binary thing. generally imagine in these areas there is always room for more funding, at least in the horizon of a year or more.
It’s just a combination of
diminishing returns, perhaps past a threshold of ‘these interventions are better than alternatives’
limited capacity because of short-run constraints that take some time to adjust (hire more staff, negotiate more vaccine access, assess new areas to administer vaccines)
Almost no cost function should have an ‘infinite slope’ past a certain output, particularly not in the non-very-short run. Similarly here.
Links:
Assessment of GAVI (vaccines) for Open Philanthropy
Discussions of ‘should EAs still support AMF if big donors will ’fill all underfunding″ on social media (locate)